GlassScriptPhysician profile
Diane Adamczyk
NPI 1710987326
$3,173.19
in general payments reported to CMS, 2019-2025
5 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $858 · 2021: $88.00 · 2022: $196 · 2023: $1,356 · 2024: $486 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,275 · Food and Beverage: $756.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,275.00 |
| Food and Beverage | $755.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $1,595.36 | 2023-2025 | Oxervate |
| Allergan, INC. | $945.77 | 2019-2021 | |
| Abbvie INC. | $394.43 | 2022-2025 | |
| Bausch & Lomb Americas INC. | $120.58 | 2024 | Miebo, Xiidra |
| Novartis Pharmaceuticals Corporation | $117.05 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Adamczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.